Registry for Gastroparesis
(GpR4 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is an observational study focusing on individuals with symptoms of gastroparesis or functional dyspepsia, conditions that affect how the stomach empties food. The researchers aim to gather information on these conditions by collecting data from participants, such as their symptoms and test results. Participants will complete questionnaires and undergo tests like a nutrient drink test and a gastric emptying study. This trial suits those who have experienced symptoms like nausea, vomiting, or stomach pain for at least 12 weeks and can complete specific medical tests. As an unphased trial, it offers participants the opportunity to contribute valuable data that could lead to better understanding and management of their condition.
Do I need to stop my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. However, you cannot participate if you use narcotic painkillers more than three days a week.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to gather comprehensive data on gastroparesis, a condition where the stomach cannot empty properly. Unlike treatments that focus solely on symptom relief, this observational study seeks to understand the condition more deeply by tracking a wide range of patient experiences and health outcomes. This could lead to identifying new patterns or causes of gastroparesis, ultimately paving the way for more targeted and effective treatments in the future. By compiling extensive real-world data, researchers hope to uncover insights that could revolutionize how we approach and manage this challenging digestive disorder.
Who Is on the Research Team?
Jay Pasricha, MD
Principal Investigator
Mayo Clinic
Henry Parkman, MD
Principal Investigator
Temple University
David Shade, JD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including gastric emptying scintigraphy and evaluation of Carnett's sign
Observational Period
Participants are observed for changes in symptom severity and gastric emptying over time
Follow-up
Participants are monitored for safety and effectiveness after the observational period
What Are the Treatments Tested in This Trial?
Interventions
- Observational Study
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Wake Forest University
Collaborator
Massachusetts General Hospital
Collaborator
Texas Tech University Health Sciences Center, El Paso
Collaborator
Temple University
Collaborator
University of Louisville
Collaborator
Mayo Clinic
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.